Longitudinal MRI-based fusion novel model to predict pathological complete response in breast cancer treated with neoadjuvant chemotherapy: A multicenter, retrospective study.

The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...

Throughout the year, members can sign-up to participate in virtual meetings focused on specific training or career topics. Members can select from a list of mentors per meeting topic. At the end of ...

The scholarship application period for the 2025 ASCO Annual Meeting will open on Monday, March 10 at 10:00 AM and close on Monday, March 17 at 5:00 PM (ET). Please read the eligibility and criteria ...

The Resilience Skills Training Program aims to improve physician wellness in oncology through a proactive approach. The program targets current trainees to help create a culture change surrounding ...

Recruiting and developing oncology practice staff takes care and strategy. ASCO can be a unique resource as you search for ideal candidates and work to bolster the expertise and efficiency of your ...

Association of early completion of portable medical orders with inpatient costs at end-of-life for patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

The Association for Clinical Oncology (ASCO) works to ensure that all people with cancer have access to high-quality, affordable cancer care, no matter who they are or where they live. ASCO advocates ...

SABRE: Assessment of safety and efficacy of 64 Cu-SAR-BBN in patients with PSMA-negative biochemical recurrent prostate cancer.

To learn more about the Oncology Medical Home standards and ASCO Certified recognition from ASCO, please click the button below and submit your questions. ASCO Certified has launched a new application ...

Development and validation of a prognostic score for overall survival integrating baseline metabolically active tumor volume measured by 18 F-FDG PET/CT and clinical factors for metastatic colorectal ...

Association of positive ctDNA-based minimal residual disease assays during surveillance and undiagnosed concomitant radiographic recurrences in colorectal cancer (CRC): Results from the MD Anderson ...